State Of Wisconsin Investment Board Design Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.99 - $7.64 $204,091 - $312,476	40,900 Added 94.9%	84,000 $529,000
Q1 2023 May 15, 2023	BUY	$5.5 - $9.77 $237,050 - $421,087	43,100 New	43,100 $248,000
Q2 2022 Aug 15, 2022	SELL	$9.91 - $17.33 $352,796 - $616,947	-35,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.17 - $20.89 $203,294 - $380,198	18,200 Added 104.6%	35,600 $575,000
Q2 2021 Aug 12, 2021	BUY	$19.02 - $29.78 $330,948 - $518,172	17,400 New	17,400 $346,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.